These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 471140)

  • 1. Absorption and action of insulin added to peritoneal dialysate in dogs.
    Shapiro DJ; Blumenkrantz MJ; Levin SR; Coburn JW
    Nephron; 1979; 23(4):174-80. PubMed ID: 471140
    [No Abstract]   [Full Text] [Related]  

  • 2. Estimate the insulin absorption in diabetic patients on peritoneal dialysis.
    Pantsulaia T; Chokhonelidze I; Lomitashvili T
    Georgian Med News; 2006 Nov; (140):28-30. PubMed ID: 17179582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin therapy during peritoneal dialysis: pros and cons of various forms of administration.
    Quellhorst E
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S92-6. PubMed ID: 11792768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of peritonitis on insulin and glucose absorption during peritoneal dialysis in diabetic rats.
    Mactier RA; Moore H; Khanna R; Shah J
    Nephron; 1990; 54(3):240-4. PubMed ID: 2179758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronan prevents the decreased net ultrafiltration caused by increased peritoneal dialysate fill volume.
    Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
    Kidney Int; 1998 Feb; 53(2):496-502. PubMed ID: 9461112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraperitoneal insulin for control of blood sugar in diabetic patients during peritoneal dialysis.
    Crossley K; Kjellstrand CM
    Br Med J; 1971 Jan; 1(5743):269-70. PubMed ID: 5100499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal absorption of insulin in dogs.
    Harai S; Ikenaga T; Matsuzawa T
    Diabetes; 1978 Mar; 27(3):296-9. PubMed ID: 25215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraperitoneal administration of insulin during peritoneal dialysis of diabetics with terminal renal failure.
    Anderson KE; Petersen PH
    Int J Artif Organs; 1981 Jul; 4(4):162-7. PubMed ID: 7035377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin Resistance in Nondiabetic Peritoneal Dialysis Patients: Associations with Body Composition, Peritoneal Transport, and Peritoneal Glucose Absorption.
    Bernardo AP; Oliveira JC; Santos O; Carvalho MJ; Cabrita A; Rodrigues A
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2205-12. PubMed ID: 26507143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Peritoneal dialysis for diabetic nephropathy: a case of intraperitoneal insulin administration].
    Abe T; Kusumi H; Kanazawa M
    Hinyokika Kiyo; 1972 Mar; 18(3):133-6. PubMed ID: 5065298
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intermittent peritoneal chronic dialysis in diabetic patients: effect of the technique on blood glucose and protein loss during the procedure].
    García Ortiz R; Gómez M; Olea C
    Rev Med Chil; 1989 Dec; 117(12):1367-73. PubMed ID: 2519375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of three chronic dialysis models.
    Peng WX; Guo QY; Liu SM; Liu CZ; Lindholm B; Wang T
    Adv Perit Dial; 2000; 16():51-4. PubMed ID: 11045261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dialysate glucose load on plasma glucose and glucoregulatory hormones in CAPD patients.
    Armstrong VW; Creutzfeldt W; Ebert R; Fuchs C; Hilgers R; Scheler F
    Nephron; 1985; 39(2):141-5. PubMed ID: 3883205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraperitoneal administration of insulin during peritoneal dialysis of diabetic patients with terminal renal failure.
    Andersen KE; Petersen PH
    Proc Eur Dial Transplant Assoc; 1981; 18():206-11. PubMed ID: 7036148
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intraperitoneal insulin in continuous ambulatory peritoneal dialysis].
    Riambau E; Aubia J; Llorach I; Lloveras J; Masramón J; Orfila A; Llorach M
    Rev Clin Esp; 1982 Mar; 164(5):333-4. PubMed ID: 7048442
    [No Abstract]   [Full Text] [Related]  

  • 16. Solutes transport characteristics in peritoneal dialysis: variations in glucose and insulin serum levels.
    da Silva DR; Figueiredo AE; Antonello IC; Poli de Figueiredo CE; d'Avila DO
    Ren Fail; 2008; 30(2):175-9. PubMed ID: 18300117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Permanent control of blood glucose in diabetic patients using continuous ambulatory peritoneal dialysis. Continuous insulin infusion by the intraperitoneal route].
    Martinand A; Belleville I; Cabanne JF; Chuet C; Morey W; Brun JM; Rifle G
    Presse Med; 1984 Jan; 13(3):165. PubMed ID: 6229747
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics of transperitoneal insulin transport.
    Widerøe TE; Dahl KJ; Smeby LC; Balstad T; Cruischank-Flakne S; Følling I; Simondsen O; Ahlmen J; Jørstad S
    Nephron; 1996; 74(2):283-90. PubMed ID: 8893142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium carbonate decreases ultrafiltration rates in an experimental model of PD.
    Lal SM; Moore HL; Groshong TD; Nolph KD
    Int J Artif Organs; 1994 Nov; 17(11):573-5. PubMed ID: 7744515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diurnal variations of blood glucose by continuous blood glucose monitoring in peritoneal dialysis patients with diabetes.
    Mori T; Chida M; Oba I; Koizumi K; Furusho M; Tanno M; Naganuma E; Ito S
    Adv Perit Dial; 2014; 30():54-9. PubMed ID: 25338422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.